These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 309555)

  • 21. [Immunologic characterization and prognosis of acute infantile lymphatic leukemia].
    Correra A; Tontoli N; Vetrella A; Saviano P; De Masi RV
    Pediatria (Napoli); 1980 Sep; 88(3):463-71. PubMed ID: 6971432
    [No Abstract]   [Full Text] [Related]  

  • 22. Advances in the management of childhood leukemia.
    Bowman WP
    Tex Med; 1985 Mar; 81(3):39-44. PubMed ID: 3885465
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute lymphoblastic leukemic and lymphoma cells with thymus-derived (T) markers.
    Kersey JH; Nesbit ME; Luckasen JR; Hallgren HM; Sabad A; Yunis EJ; Gajl-Peczalska KJ
    Mayo Clin Proc; 1974 Aug; 49(8):584-7. PubMed ID: 4546716
    [No Abstract]   [Full Text] [Related]  

  • 24. [Characteristics of acute lymphoblastic leukemia of children with 0-cells in the bone marrow and a predominance of T- or B-cells in the peripheral blood].
    Lenskaia RV; Samochatova EV; Rumiantsev AG; Izotova TA
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):20-4. PubMed ID: 6974356
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunologic cell markers in acute lymphoblastic leukemia in children].
    Grigor'iants LIa
    Eksp Onkol; 1987; 9(2):28-30. PubMed ID: 3495426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute lymphoblastic leukemic cells with T (thymus-derived) lymphocyte markers.
    Kersey JH; Sabad A; Gajl-Peczalska K; Hallgren HM; Yunis EJ; Nesbit ME
    Science; 1973 Dec; 182(4119):1355-6. PubMed ID: 4586464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of prognostic value of immunological markers in acute lymphoblastic leukemia (ALL) after intensification of treatment schedule.
    Bogusławska-Jaworska J; Rodziewicz B
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):392-5. PubMed ID: 3492185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute lymphoblastic leukaemia of the B-cell type refractory to intensive chemotherapy.
    Kawashima K; Morishima Y; Kato Y; Takeyama H; Kobayashi M; Suzuki K; Ueda R; Yamada K; Naito K; Yoshikawa S; Sako F
    Clin Exp Immunol; 1978 Mar; 31(3):448-55. PubMed ID: 306904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N; Derre M; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [T and B-lymphocytes in acute lymphoblastic leukemia of childhood at diagnosis and during the initial stages of therapy (author's transl)].
    De Martino M; Biagioli EC; Pisanu C; Lippi A; Novembre E; Guazzelli C; Vierucci A
    Haematologica; 1979 Aug; 64(4):442-54. PubMed ID: 121579
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: Unmasking the heterogeneity of acute lymphoblastic leukemia.
    Gelfand EW; Chechik BE
    N Engl J Med; 1976 Jan; 294(5):275-6. PubMed ID: 1081642
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of monoclonal antibodies and molecular biology technics in the immunological classification of acute lymphoblastic leukemias].
    Chen Z; Sigaux F
    Pathol Biol (Paris); 1986 Jan; 34(1):5-7. PubMed ID: 2939390
    [No Abstract]   [Full Text] [Related]  

  • 33. [Immunologic analysis of acute lymphoblastic leukemia in adults].
    Kita K; Nasu K; Kamesaki H; Doi S; Tezuka H; Takiuchi Y; Tatsumi E; Fukuhara S; Nishikori M; Uchino H
    Nihon Ketsueki Gakkai Zasshi; 1984 Aug; 47(5):1115-27. PubMed ID: 6334962
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymphocyte membrane markers in acute lymphoblastic leukaemia.
    Aiuti F; Papa G; Lacava V; Ciarla MV; D'Amelio R; Garofalo J
    Br J Haematol; 1974 Aug; 27(4):635-41. PubMed ID: 4547490
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunologic characteristics of T and B lymphocytes in patients with chronic lymphoid leukemia].
    Tardieu M; Thériault D; Hébert J; Daguillard F
    Union Med Can; 1974 Mar; 103(3):431-4. PubMed ID: 4595150
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunologic markers in the diagnosis of the acute lymphocytic leukemias.
    Hecht F; Hecht BK; Vyvial TM; Jarzabek V; Morgan R
    Ariz Med; 1982 Oct; 39(10):640-3. PubMed ID: 6983337
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiology and immunological phenotype of childhood ALL in Greece.
    Papamichail M; Megalakaki C; Cosmidou H; Maniatis A
    Leuk Res; 1985; 9(6):773-5. PubMed ID: 3874335
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunological and molecular classification of acute lymphoblastic leukemia.
    Foa R; Migone N; Gavosto F
    Haematologica; 1986; 71(4):277-85. PubMed ID: 3096821
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunological classification of acute lymphoblastic leukaemias: evaluation of its clinical significance in a hundred patients.
    Brouet JC; Valensi F; Daniel MT; Flandrin G; Preud'homme JL; Seligmann M
    Br J Haematol; 1976 Jul; 33(3):319-28. PubMed ID: 1084157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Indicators of cellular immunity and the incidence of infectious-inflammatory diseases during clinico-hematological remission in patients with acute leukemia].
    Vinogradova IuE; Ivanina EK
    Ter Arkh; 1984; 56(6):46-50. PubMed ID: 6332389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.